Eternity in Medical Information -- Medisurf


Search \| Web Directory, News, Variable useful Information, PubMed In Medine, All

Category Select :

Items 181 ~ 200 of 25905, Page 10 of 1296

181. Japanese Red Cross Society Selects Abbott Technology to Screen Country''s Blood and Plasma Supply

LONG-TERM AGREEMENT BETWEEN JAPANESE RED CROSS SOCIETY AND ABBOTT BRINGS TOGETHER TWO GLOBAL LEADERS IN BLOOD AND PLASMA SCREENING, HELPING ENSURE A SAFE AND EFFICIENT BLOOD SUPPLY ACROSS JAPAN

01/17/2019 Abbott

182. FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy

01/16/2019 U.S. FOOD & DRUG ADMINISTRATION

183. Abbott To Acquire Cephea Valve Technologies, Inc.

Acquisition to further bolster Abbott's leading position in therapies for mitral valve disease, the most common type of heart valve ailment

01/16/2019 Abbott

184. Statement from FDA Commissioner, Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies

01/15/2019 U.S. FOOD & DRUG ADMINISTRATION

185. Medtronic Launches Mobile App That Communicates Directly with World''s First Smartphone-Connected Pacemakers

MyCareLink Heart(TM) Mobile App Allows Pacemaker Patients to Easily Stay Connected with Their Clinics

01/15/2019 Medtronic

186. Personalized Treatment Benefits Kidney Cancer Patients

Patients who have risk factors for worsening kidney disease may benefit from personalized treatment plans / Researchers constructed a simulation model to assess the impact of different treatment approaches in patients with small renal tumors. /

01/15/2019 Radiological Society of North America

187. AAOS Praises Introduction of Hospital Competition Act

01/15/2019 American Academy of Orthopaedic Surgeons

188. Merck’s KEYTRUDA® (pembrolizumab) Reduced Risk of Death by 31 Percent Compared to Chemotherapy in Previously Treated Patients with Advanced Esophageal or Esophagogastric Junction Carcinoma Whose Tumors Expressed PD-L1 (CPS ≥10)

Results from Phase 3 KEYNOTE-181 Trial to be Presented at 2019 Gastrointestinal Cancers Symposium (ASCO GI)

01/14/2019 MERCK

189. FDA Approves World''s First Device for Treatment of Premature Babies and Newborns with an Opening in Their Hearts (a Common Congenital Defect)

First and only minimally invasive, transcatheter treatment specifically approved for premature babies with a patent ductus, a life-threatening opening in their heart

01/14/2019 Abbott

190. Abbott and Malaria No More Work Together to End Malaria in Odisha, India

Abbott to supply rapid diagnostic tests critical for malaria detection and surveillance, technical expertise and funding support / Initiative focuses on Odisha, the state with the highest burden of malaria in India

01/11/2019 Abbott

191. Online ACS Community Helps Researchers Collaborate

TheoryLab® is an online community exclusively for scientists and clinical professionals who have a current or previous relationship with the American Cancer Society. The goal is to provide a place for some of the brightest minds in cancer research to work together to accelerate our progress toward a world without cancer.

01/10/2019 American Cancer Society

192. Facts & Figures 2019: US Cancer Death Rate has Dropped 27% in 25 Years

The death rate from cancer in the US has declined steadily over the past 25 years, according to annual statistics reporting from the American Cancer Society.

01/08/2019 American Cancer Society

193. “Zero polio transmission and health for all”, WHO Director-General gives new year’s wish to the people of Afghanistan and Pakistan

01/08/2019 WHO

194. Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s new actions under the Pre-Cert Pilot Program to promote a more efficient framework for the review of safe and effective digital health innovations

01/07/2019 U.S. FOOD & DRUG ADMINISTRATION

195. Take a Moment With Meditation

Our busy lives can leave us frazzled and stressed. Studies show taking a mental break with meditation can quiet the mind and improve health. We’ll walk you through the basics.

01/07/2019 American Cancer Society

196. Cutting Calories With Portion Control

Portion sizes have increased over the years, making it easier for Americans to overeat. Read about creative ways to cut back on calories by eating smaller portions of meals and snacks.

01/04/2019 American Cancer Society

197. New Prediction Feature for Hypoglycemia Now Available in Sugar.IQ(TM) Personal Diabetes Assistant App, Developed by Medtronic and IBM Watson Health

IQcast Feature Aims to Predict the Likelihood of a Low Glucose Event Up to Four Hours in Advance

01/03/2019 Medtronic

198. Merck Exercises Option for NGM Bio’s Investigational Insulin Sensitizer, NGM313, for the Treatment of NASH and Type 2 Diabetes

MK-3655 (formerly known as NGM313) is a proprietary, investigational agonistic antibody that selectively activates the β-Klotho/FGFR1c receptor complex.

01/03/2019 MERCK

199. Merck’s KEYTRUDA® (pembrolizumab) Receives Five New Approvals in Japan, Including in Advanced Non-Small Cell Lung Cancer (NSCLC), as Adjuvant Therapy for Melanoma, and in Advanced Microsatellite Instability-High (MSI-H) Tumors

KEYTRUDA is the First Anti-PD-1 Approved in Japan for the First-Line Treatment of Advanced NSCLC as Both Monotherapy and in Combination with Chemotherapy / With New MSI-H Indication, KEYTRUDA is the First Cancer Therapy Approved in Japan for Use Based on a Biomarker, Regardless of Tumor Type

01/03/2019 MERCK

200. WHO Director-General concludes New Year visit to Ebola-affected areas in the Democratic Republic of the Congo

01/03/2019 WHO

경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱